Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells.
about
Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6Regulation of steroid hormone receptors and coregulators during the cell cycle highlights potential novel function in addition to roles as transcription factorsTargeting CDK6 in cancer: State of the art and new insightsThe other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axisA kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisCell-cycle-dependent regulation of androgen receptor functionIn silico 3D structure modeling and inhibitor binding studies of human male germ cell-associated kinase.Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.Thr-370 is responsible for CDK11(p58) autophosphorylation, dimerization, and kinase activity.Epigenetics of prostate cancer: beyond DNA methylationmiR-105 inhibits prostate tumour growth by suppressing CDK6 levelsGalbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.Cellular Adhesion Promotes Prostate Cancer Cells Escape from DormancyCyclin D3/CDK11p58 complex is involved in the repression of androgen receptor.Does "clock" matter in prostate cancer?AR, the cell cycle, and prostate cancer.The kinase-independent, second life of CDK6 in transcription.Targeting cell cycle and hormone receptor pathways in cancer.Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.The AR dependent cell cycle: mechanisms and cancer relevance.FBI-1 functions as a novel AR co-repressor in prostate cancer cells.miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016).Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.Crosstalk between c-Jun and TAp73alpha/beta contributes to the apoptosis-survival balance.Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.Cell cycle-coupled expansion of AR activity promotes cancer progression.Proteotranscriptomic measurements of E6-Associated Protein (E6AP) targets in DU145 prostate cancer cells.Cyclin D3 action in androgen receptor regulation and prostate cancer.C-glycosyl flavone from Urginea indica inhibits proliferation & angiogenesis & induces apoptosis via cyclin-dependent kinase 6 in human breast, hepatic & colon cancer cell lines.
P2860
Q24293466-399E57AC-A2BC-40EE-A131-459064436551Q26771541-D95439C9-E4E2-44E1-9791-60AC49E07631Q26796499-1FA7C3A2-6045-4924-8739-728869ECDAF5Q26865888-4C1B55A2-2180-4539-A2A9-BBCE533CCF32Q28296641-0B6D86C8-7FB5-4516-8966-392F42AAAE21Q30300725-D7F15612-02E8-4FFC-A0A1-81765F4DE2FDQ30367060-028DCC05-DD69-4D2A-A8DF-99F065D390DDQ33645120-DAC4A0B4-D8B1-497A-8791-FCA99A84C5BEQ34503051-C5EE0E4A-B32E-491E-91FF-B74BFA4E5D83Q34505232-CEEFBC1E-6A39-4209-95FE-C8E3AB2EB4AAQ34947109-E7F13899-D8C9-49F0-8E52-FDDBB9A2FAEAQ35109795-98030E12-5AA2-4D6D-87C2-40527335C608Q35127580-1E0B27E7-F522-41E7-AF55-A933525A6382Q35668319-CC963061-3837-47AA-8FA5-B8A837ED63D3Q36315288-DABB52E6-05FE-4B4D-AA95-1747EE346C80Q36629390-BAE5FF1D-6DBC-4C27-993D-24E88A9C5D97Q37095260-60F3165F-F670-4174-B7B4-E96BF828179BQ37259166-BDD16304-8599-4439-A52C-732B9290C806Q37502364-7ED2208B-5010-42CC-B4E9-7FC68E612AF5Q37682137-07B9A9AD-C15A-4466-9AA5-2503158716C6Q37904028-29FC9980-CB0E-4DC1-BBEB-F58A835C4093Q38341215-1AD6E3D0-C608-495E-8773-996DC848D0D0Q38701099-CFA912F7-5C79-4F39-A5FD-12A21C361DFDQ38949247-BA77CE5B-7FA5-424B-BC66-320159138203Q39258781-DA14CBD7-E14B-4A46-A363-0EEC34EE7BD0Q39565566-395E389C-CC2B-4AFB-AC9C-EA3CB7C7534FQ39967217-334AB431-5560-4F10-8D80-930E334A7086Q40565537-5480F5E0-9644-471E-9EE0-25E96C756A89Q49791547-36127957-12E0-48B1-ADFB-3CC26070C9B2Q52584077-3762B547-CE1B-4400-A898-12136758EB56Q54977938-F992C8E7-6914-484A-AFDB-E7BE9ED0844A
P2860
Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@ast
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@en
type
label
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@ast
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@en
prefLabel
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@ast
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@en
P2093
P2860
P356
P1476
Cyclin-dependent kinase 6 asso ...... vity in prostate cancer cells.
@en
P2093
I Bernard Weinstein
Jin T E Lim
Mahesh Mansukhani
P2860
P304
P356
10.1073/PNAS.0501203102
P407
P577
2005-03-24T00:00:00Z